Skip to main content
. Author manuscript; available in PMC: 2015 Dec 30.
Published in final edited form as: Urology. 2015 Mar;85(3):703.e1–703.e6. doi: 10.1016/j.urology.2014.10.020

Table 3.

Association between CD8 density and outcome in the subset of 50 cystectomies with invasive (≥pT1) urothelial carcinoma

CD8 Density Overall Survival
Disease-specific Survival
OR (95% CI) P Value OR (95% CI) P Value
Unadjusted 0.12 (0.02–0.68) .02 0.14 (0.03–0.78) .02
Adjusted for demographic parameters* 0.1 (0.02–0.69) .02 0.06 (0.01–0.53) .01
Adjusted for pathologic parameters 0.1 (0.01–0.69) .02 0.05 (0.01–0.62) .02
Adjusted for neoadjuvant therapy 0.04 (0.004–0.46) .01 0.1 (0.02–0.6) .01
Adjusted for intravesical therapy 0.09 (0.01–0.58) .01 0.11 (0.02–0.7) .02

CI, confidence interval; OR, odds ratio.

*

Age and gender.

pT category, lymph node metastasis and lymphovascular invasion.

Neoadjuvant chemotherapy and neoadjuvant radiotherapy.